Senior Director, Downstream Marketing
Saluda Medical is a commercial‑stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed‑loop neuromodulation platform. The company’s proprietary technology senses and measures neural responses to stimulation and automatically adjusts therapy based on real‑time neurophysiological feedback.
Saluda Medical’s first product, the Evoke® System, is designed to deliver known, consistent, and personalized spinal cord stimulation therapy by objectively measuring neural responses and maintaining therapy within a prescribed therapeutic window. Saluda Medical is headquartered in Minneapolis, Minnesota.
At Saluda, we challenge boundaries. We innovate and think beyond the conventional. Our focus is to revolutionize the standard of care in neuromodulation to positively impact patient’s lives.
The Role:
The Director / Senior Director, Downstream Marketing owns global downstream strategy and execution for the Evoke™ platform, with primary accountability for U.S. commercialization. This leader serves as a core thought partner to senior commercial leadership, and is the single point of accountability for downstream performance. This role will directly impact Saluda’s ability to set a clear market differentiation of Evoke™, accelerated physician adoption and utilization, strong field confidence, and delivery of sustained commercial growth through a scalable downstream marketing engine.
Key Responsibilities:
- Defines and leads the global commercial marketing strategy for the Evoke SCS System, identifying white space opportunities and developing bold go-to-market approaches that disrupt legacy market dynamics.
- Translate enterprise strategy into clear commercial priorities, investment decisions, and execution plans across regions.
- Own and evolve the Evoke™ value proposition grounded in clinical evidence, technology leadership, and economic impact.
- Partner with Sales leadership to ensure tight alignment between downstream strategy and field execution.
- Lead development of best-in-class sales enablement tools, commercial programs, and customer-facing campaigns.
- Oversee downstream commercialization for new indications, upgrades, and major product initiatives.
- Establish enterprise KPIs tied to adoption, utilization, and growth; drive performance management and optimization.
- Lead competitive intelligence strategy and executive-level competitive response planning.
- Build and leverage senior relationships with Key Opinion Leaders and external partners.
- Partner with Medical Affairs and Professional Education to ensure evidence-driven, integrated commercial execution.
- Ensure excellence, compliance, and consistency across congresses, peer-to-peer programs, and major commercial moments.
- Drive operational rigor, accountability, and cross-functional alignment across downstream initiatives.
Key Requirements:
- 12+ years of progressive medical device marketing experience with deep downstream leadership responsibility.
- 7+ years leading U.S. or global downstream/commercial marketing in highly competitive categories.
- Demonstrated success launching and scaling complex, evidence-driven therapies.
- Executive presence with the ability to influence senior commercial and clinical stakeholders.
- Strong analytical orientation with fluency in KPIs, dashboards, and performance management.
- Deep understanding of FDA medical device regulations, quality systems, and legal review requirements.
- Unquestioned ethics, integrity, and sound judgment.
Desired Requirements:
- Experience in neuromodulation, chronic pain, or similarly complex therapeutic categories.
- MBA or advanced business degree.
- Prior experience leading downstream marketing teams and developing high-performing leaders.
Saluda Medical embraces diversity and equal opportunity. We are committed to building a team representative of a variety of backgrounds, perspectives, and skills. We believe people are the source of our inspiration and innovation.
Saluda Medical does not accept non-solicited resumes or candidate submittals from search/recruiting agencies not already on Saluda Medical’s approved agency list. Unsolicited resumes or candidate information submitted to Saluda Medical by search/recruiting agencies not already on Saluda Medical’s approved agency list shall become the property of Saluda Medical.
Skills Required
- 12+ years of progressive medical device marketing experience
- 7+ years leading U.S. or global downstream/commercial marketing
- Demonstrated success launching and scaling complex therapies
- Executive presence to influence stakeholders
- Strong analytical orientation with fluency in KPIs
- Deep understanding of FDA regulations
- Unquestioned ethics and integrity
What We Do
Saluda Medical is a global company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies designed to treat debilitating neurological disorders. The company’s first product, the Evoke® System, is the only ECAP-controlled closed-loop spinal cord stimulation (SCS) system and is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable low back pain, and leg pain. The Evoke System instantaneously reads, records, and responds to the nerves’ response to stimulation to provide continually optimized therapy and is proven to be superior to open-loop SCS for the treatment of overall trunk and/or limb pain. 12-month results from the EVOKE Study, the first double-blind randomized controlled trial (RCT) used in support of Premarket Approval (PMA) in spinal cord stimulation history, were published in The Lancet Neurology and 24-month results have since been published JAMA Neurology. Both studies are poised to set new clinical standards for long-term pain relief and improvements in physical and emotional functioning, sleep quality and health-related quality of life. In the EU, Evoke is CE Marked and commercially available. In the U.S., Evoke is FDA-approved and will be available when the Company implements its full commercial release in 2023. Saluda Medical is a privately held company with headquarters in Bloomington, MN, USA. To learn more about Saluda Medical, including the risks & important safety information, visit www.saludamedical.com









